Giant Pfizer looking to shed close to 2,000 jobs as it crafts a ‘simpler’ management structure
Pfizer is slimming down the head count ahead of Albert Bourla’s official coronation as the new CEO at the start of 2019.
The New York-based pharma giant has set its sights on some increased efficiency in the way it’s structured, and that will require them to shed about 2% of its 90,000-some work force, or roughly close to 2,000 jobs. And they’re offering buyouts to encourage some staffers to leave voluntarily.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
